Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethyl Sulfoxide SCHEMBL16497660 | 0.83 | CA2 (0.38) | SLC34A1FDPSGGPS1CA2 | |
| Tetramethylammonium Ion SCHEMBL1130116 | 0.80 | SLC34A1 (0.41) | SLC34A1CA2KDM4ECYP2C19KMT2A | |
| SCHEMBL28492233 | 0.79 | SLC34A1 (0.47) | SLC34A1CA2KDM4ECYP2C19KMT2A | |
| Lithium Ion SCHEMBL28390201 | 0.78 | — | — | |
| SCHEMBL583553 | 0.78 | — | — | |
| Ammonia Solution, Strong SCHEMBL7594155 | 0.76 | SLC34A1 (0.53) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Lithium Ion SCHEMBL29135346 | 0.74 | SLC34A1 (0.50) | SLC34A1FDPSGGPS1CA2KDM4E | |
| SCHEMBL29167943 | 0.74 | SLC34A1 (0.50) | SLC34A1FDPSGGPS1CA2KDM4E | |
| Ammonia Solution, Strong SCHEMBL1289336 | 0.74 | — | — | |
| Fluoride Ion SCHEMBL1708173 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210347941-A1 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS (US) | 2021-11-11 | — | — | US | claimed |
| US-20190055354-A1 | METHODS FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS | 2019-02-21 | — | — | US | claimed |
| US-20170073468-A1 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS | 2017-03-16 | — | — | US | claimed |
| US-8604159-B2 | Method for preparing functionalized polymers from polymer alcohols | NEKTAR THERAPEUTICS (US) | 2013-12-10 | — | — | US | claimed |
| EP-1656410-B1 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS (US) | 2010-03-10 | — | — | EP | claimed |
| EP-1656410-A2 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | Nektar Therapeutics Al, Corporation (US) | 2006-05-17 | — | — | EP | claimed |
| US-20050054816-A1 | Method for preparing functionalized polymers from polymer alcohols | NEKTAR THERAPEUTICS | 2005-03-10 | — | — | US | claimed |
| WO-2005010075-A2 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2005-02-03 | — | — | WO | claimed |
| US-20210347941-A1 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS (US) | 2021-11-11 | — | — | US | disclosed |
| US-10941248-B2 | Methods for preparing functionalized polymers from polymer alcohols | NEKTAR THERAPEUTICS (US) | 2021-03-09 | — | — | US | disclosed |
| US-20190055354-A1 | METHODS FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS | 2019-02-21 | — | — | US | disclosed |
| US-10144804-B2 | Method for preparing functionalized polymers from polymer alcohols | NEKTAR THERAPEUTICS (US) | 2018-12-04 | — | — | US | disclosed |
| US-20170073468-A1 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS | 2017-03-16 | — | — | US | disclosed |
| US-20140073802-A1 | MALEIMIDYL POLYMER DERIVATIVES | NEKTAR THERAPEUTICS (US) | 2014-03-13 | — | — | US | disclosed |
| US-8604159-B2 | Method for preparing functionalized polymers from polymer alcohols | NEKTAR THERAPEUTICS (US) | 2013-12-10 | — | — | US | disclosed |
| EP-1656410-B1 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS (US) | 2010-03-10 | — | — | EP | disclosed |
| EP-1656410-A2 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | Nektar Therapeutics Al, Corporation (US) | 2006-05-17 | — | — | EP | disclosed |
| US-20050054816-A1 | Method for preparing functionalized polymers from polymer alcohols | NEKTAR THERAPEUTICS | 2005-03-10 | — | — | US | disclosed |
| WO-2005010075-A2 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2005-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210347941-A1 | METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | ADH1C, ADH1A, ADH5 | SLC34A1 3609/4885FDPS 1048/4885GGPS1 808/4885 |
| US-10144804-B2 | Method for preparing functionalized polymers from polymer alcohols | ADH1C, ADH1A, ADH5 | SLC34A1 2417/4885FDPS 563/4885GGPS1 1486/4885 |
| US-20190055354-A1 | METHODS FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS | ADH1C, ADH1A, ADH5 | SLC34A1 2511/4885FDPS 835/4885GGPS1 1788/4885 |
| US-10941248-B2 | Methods for preparing functionalized polymers from polymer alcohols | ADH1C, ADH1A, ADH5 | SLC34A1 2511/4885FDPS 835/4885GGPS1 1788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.